You may be able to participate in this trial if you:
Are 40 years of age or older
Have been diagnosed with COPD at least 12 months prior to the screening visit
What is this trial testing?
This trial is studying whether an add-on inhaler (in addition to your current inhalers) has the potential to reduce the risk of future COPD exacerbations. We anticipate involvement in the study will last a little over a year and will include about 8 visits with our study team.
What is clinical research?
Clinical research is how we get new therapies, devices and medications to the general public. Clinical trials test the safety and effectiveness of the medicines and devices created by biopharmaceutical companies. The Food and Drug Administration (FDA) approves all medicines and devices before they become available to consumers.